Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil

2018; American Society for Microbiology; Volume: 56; Issue: 12 Linguagem: Inglês

10.1128/jcm.00961-18

ISSN

1098-660X

Autores

Vanessa Da Silva Brito, Fred Luciano Neves Santos, Noilson Lázaro Gonçalves, Théssika Hialla Almeida Araújo, Davi Silva Vale Nascimento, Felicidade Mota Pereira, Ney Boa‐Sorte, Maria Fernanda Rios Grassi, Adele Caterino‐de‐Araujo, Bernardo Galvão–Castro,

Tópico(s)

Animal Disease Management and Epidemiology

Resumo

Serological screening for human T-cell lymphotropic virus type 1 (HTLV-1) is usually performed using enzyme-linked immunosorbent assay (ELISA), particle agglutination, or chemiluminescence assay kits. Due to an antigen matrix improvement entailing the use of new HTLV antigens and changes in the format of HTLV screening tests, as well as newly introduced chemiluminescence assays (CLIAs), a systematic evaluation of the accuracy of currently available commercial tests is warranted.

Referência(s)